nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.02.2003 | Review Article

Darier’s Disease

Epidemiology, Pathophysiology, and Management

verfasst von: Dr Susan M. Cooper, Susan M. Burge

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 2/2003

Einloggen, um Zugang zu erhalten

Abstract

Darier’s disease is a rare cutaneous disease with an autosomal dominant mode of inheritance. Greasy papules and plaques arise on the seborrheic areas and in the flexures and almost all patients have nail abnormalities. Acantholysis and dyskeratosis are the typical histological findings. The underlying defect is a result of mutations in the ATP2A2 gene on chromosome 12q23-24 that encodes for a sarco/endoplasmic reticulum calcium ATPase (SERCA 2). Acantholysis is thought to result from desmosome breakdown. Darier’s disease is an example of a dominantly inherited disease caused by haplo-insufficiency. Oral retinoids are the most effective treatment but their adverse effects are troublesome. Topical retinoids, topical corticosteroids, surgery, and laser surgery have their advocates but evidence for efficacy is sparse.

Darier J. Psorospermose folliculaire vegetante. Ann Dermatol Syphilol 1889; 10: 597–612

White JC. Acase of keratosis (ichthyosis) follicularis. J Cutan Genito-Urin Dis 1889; 7: 201–209

Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet 1999; 21: 271–277PubMedCrossRef

Svendson IB, Albrectsen B. The prevalence of dyskeratosis follicularis (Darier’s disease) in Denmark. Acta Derm Venereol 1959; 39: 256–259

Wilkinson JD, Marsden RA, Dawber RPR. Review of Darier’s disease in the Oxford region. Br J Dermatol 1977; 97 Suppl. 15: 15–16CrossRef

Munro CS. The phenotype of Darier’s disease: penetrance and expressivity in adults and children. Br J Dermatol 1992; 127: 126–130PubMedCrossRef

Burge SM, Garrod DR. An immunohistological study of desmosomes in Darier’s disease and Hailey-Hailey disease. Br J Dermatol 1991; 124: 242–251PubMedCrossRef

Burge SM, Cederholm-Williams SA, Garrod DR, et al. Cell adhesion in Hailey-Hailey disease and Darier’s disease:immunocytological and explant-tissue-culture studies. Br J Dermatol 1991; 125: 426–435PubMedCrossRef

Sudbrak R, Brown J, Dobson-Brown C, et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca (2+) pump. Hum Mol Genet 2000; 9: 1131–1140PubMedCrossRef

10.

Zhao XS, Min Shin D, Liu LH, et al. Plasticity and adaption of Ca2+ signaling and Ca2+ dependent exocytosis in SERCA2+/- mice. EMBO J 2001; 20 (11): 2680–2689PubMedCrossRef

11.

Sakuntabhai A, Burge S, Monk S, et al. Spectrum of novel ATP2A2 mutations in patients with Darier’s disease. Hum Mol Genet 1999; 8 (9): 1611–1619PubMedCrossRef

12.

Ruiz-Perez VL, Carter SA, Healey E, et al. ATP2A2 mutations in Darier’s disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of class. Hum Mol Genet 1999; 8 (9): 1621–1630PubMedCrossRef

13.

Jacobsen NJO, Lyons I, Hoogendoorn B, et al. ATP2A2 mutations in Darier’s disease and their relationship to neuropsychiatric phenotypes. Hum Mol Genet 1999; 8 (9): 1631–1636PubMedCrossRef

14.

Sakuntabhai A, Dhitavat J, Burge S, et al. Mosaicism for ATP2A2 mutations causes segmental Darier’s disease. J Invest Dermatol 2000; 115: 1144–1147PubMedCrossRef

15.

Burge SM, Wilkinson JD. Darier-White disease: a review of the clinical features in 163 patients. J Am Acad Dermatol 1992; 27 (1): 40–50PubMedCrossRef

16.

Coulson IH, Misch KJ. Haemorrhagic Darier’s disease. J Roy Soc Med 1989; 82: 365–366PubMed

17.

Macleod RI, Munro CS. The incidence and distribution of oral lesions in patients with Darier’s disease. Br Dent J 1991; 171: 133–136PubMedCrossRef

18.

Graham-Brown RAC, Mann BS, Downton D, et al. Darier’s disease with salivary gland obstruction. J Roy Soc Med 1983; 76: 609–611PubMed

19.

Venencie PY, Dusser A, Fabre M, et al. Maladie de Darier et encephalopathie evolutive: une observation familiale. Ann Pediatr 1996; 43: 713–715

20.

Harris A, Burge SM, Dykes PJ, et al. Handicap in Darier’s disease and Hailey-Hailey disease. Br J Dermatol 1996; 135: 959–963PubMedCrossRef

21.

Telfer NR, Burge SM, Ryan TJ. Vesico-bullous Darier’s disease. Br J Dermatol 1990; 122: 831–834PubMedCrossRef

22.

Katta R, Reed J, Wolf JE. Cornifying Darier’s disease. Int J Dermatol 2000; 39: 844–845PubMedCrossRef

23.

Romano C, Massai L, Alessandrini C, et al. A case of acral Darier’s disease. Dermatology 1999; 199 (4): 365–368PubMedCrossRef

24.

Cianchini G, Colonna L, Camaioni D, et al. Acral Darier’s disease successfully treated with adapalene. Acta Derm Venereol 2001; 81 (1): 57–58PubMedCrossRef

25.

Foresman PL, Goldsmith LA, Gunn L, et al. Haemorrhagic Darier’s disease. Arch Dermatol 1993; 129: 511–512PubMedCrossRef

26.

McKenna KE, Walsh MY, Burrows D. Treatment of unilateral Darier’s disease with topical isotretinoin. Clin Exp Dermatol 1999; 24 (5): 425–427PubMedCrossRef

27.

Berth-Jones J, Hutchinson PE. Darier’s disease with perifollicular depigmentation. Br J Dermatol 1989; 120: 827–830PubMedCrossRef

28.

Peterson CM, Lesher JL, Sangueza OP. A unique variant of Darier’s disease. Int J Dermatol 2001; 40: 278–280PubMedCrossRef

29.

Cornelison RL, Smith EB, Knox JM. Guttate leukoderma in Darier’s disease. Arch Dermatol 1970; 102: 447–450PubMedCrossRef

30.

Burge S. Management of Darier’s disease. Clin Exp Dermatol 1999; 24 (2): 53–56PubMedCrossRef

31.

Milton GP, Peck GL, Fu JJ, et al. Exacerbation of Darier’s disease by lithium carbonate. J Am Acad Dermatol 1990; 23 (5): 926–928PubMedCrossRef

32.

Rubin MB. Lithium-induced Darier’s disease. J Am Acad Dermatol 1995; 32 (4): 674–675PubMedCrossRef

33.

Burge SM, Wilkinson JD, Miller AJ, et al. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier’s disease. Br J Dermatol 1981; 104 (6): 675–679PubMedCrossRef

34.

Fulton JE, Gross PR, Cornelius CE, et al. Darier’s disease: treatment with topical vitamin A acid. Arch Dermatol 1968; 98 (4): 396–399PubMedCrossRef

35.

Burge SM, Buxton PK. Topical isotretinoin in Darier’s disease. Br J Dermatol 1995; 133 (6): 924–928PubMedCrossRef

36.

Steijlen PM, Reifenschweiler DOH, Ramaekers FCS, et al. Topical treatment of ichthyoses and Darier’s disease with 13-cis-retinoic acid: a clinical and immunohistological study. Arch Dermatol Res 1993; 285: 221–226PubMedCrossRef

37.

Steijlen PM, Happle R, van Muijen GNP, et al. Topical treatment with 13-cisretinoic acid improves Darier’s disease and induces the expression of a unique keratin pattern. Dermatologica 1991; 182: 178–183PubMedCrossRef

38.

Hofmann B, Stege H, Bruch-Gerharz D, et al. Ichthyosen: alternative indikation fur den Einsatz von tazaroten (Zorac®). Z Hautkr 1997; 10: 767–769

39.

Micali G, Nasca MR. Tazarotene gel in childhood Darier disease. Pediatr Dermatol 1999; 16 (3): 243–244PubMed

40.

Burkhart CG, Burkhart CN. Tazarotene gel for Darier’s disease. J Am Acad Dermatol 1998; 38 (6): 1001–1002PubMedCrossRef

41.

Oster-Schmidt C. The treatment of Darier’s disease with topical tazarotene. Br J Dermatol 1999; 141 (3): 603–604PubMedCrossRef

42.

English JC, Browne J, Halbach DP. Effective treatment of localised Darier’s disease with adapelene 0.1 % gel. Cutis 1999; 63 (4): 227–230PubMed

43.

Clucas A, Verschoore M, Sorba V, et al. Adapalene 0.1 % gel is better tolerated than isotretinoin 0.0 25% gel in acne patients. J Am Acad Dermatol 1997; 36: S116–S118PubMedCrossRef

44.

Knulst AC, Baart de la Faille H, Van Vloten WA. Topical 5-fluorouracil in the treatment of Darier’s disease. Br J Dermatol 1995; 133 (3): 463–466PubMedCrossRef

45.

Bamshad J, Hilton PE. Darier’s disease: treatment with 5-fluorouracil. Cutis 1971; 8: 555–556

46.

Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization: results of a randomised, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol 1995; 131 (5): 556–560PubMedCrossRef

47.

Peck SM, Chargrin L, Sobotka H. Keratosis follicularis (Darier’s disease): a vitamin A deficiency disease. Arch Dermatol Syph 1941; 43: 223–229CrossRef

48.

Peck SM, Glick AW, Sobotka H. Vitamin A studies in keratosis follicularis (Darier’s disease). Arch Dermatol Syph 1943; 48: 17–31CrossRef

49.

Wilson D, Kay V, Charig M, et al. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate. Br J Dermatol 1988; 119: 597–607PubMedCrossRef

50.

Burge SM, Wilkinson JD. The use of Tigason (etretinate) in Darier’s disease. In: Cunliffe WJ, Miller AJ, editors. Retinoid therapy. Lancaster: MTP Press Ltd, 1984: 61–62CrossRef

51.

Van Dooren-Greebe RJ, van der Kerkhof PCM, Happle R. Acitretin monotherapy in Darier’s disease. Br J Dermatol 1989; 121: 375–379PubMedCrossRef

52.

Lauharanta J, Kanerva L, Turjanmaa K, et al. Clinical and ultrastructural effects of acitretin in Darier’s disease. Acta Derm Venereol 1988; 68 (6): 492–498PubMed

53.

Christopherson J, Geiger JM, Danneskiold-Samsoe P. A double-blind comparison of acitretin and etretinate in the treatment of Darier’s disease. Acta Derm Venereol 1992; 72: 150–152

54.

Bleiker TO, Bourke JF, Graham-Brown RA, et al. Etretinate may work where acitretin fails. Br J Dermatol 1997; 136: 368–370

55.

Gilgor RS, Chiaramonti A, Goldsmith LA, et al. Evaluation of 13-cis-retinoic acid in lamellar ichthyosis, pityriasis rubra pilaris and Darier’s disease. Cutis 1980; 25: 380–385PubMed

56.

Peck GL, Yoder FW, Olsen TG. Treatment of Darier’s disease, lamellar ichthyosis, pityriasis rubra pilaris, cystic acne and basal cell carcinoma with oral 13-cis retinoic acid. Dermatologica 1978; 157: 1211–1214CrossRef

57.

Dicken CH, Bauer EA, Hazen PG, et al. Isotretinoin treatment of Darier’s disease. J Am Acad Dermatol 1982; 6 (4): 721–726PubMedCrossRef

58.

Speight EL. Vesicobullous Darier’s disease responsive to oral prednisolone steroids. Br J Dermatol 1998; 139 (5): 934–935PubMedCrossRef

59.

Gordon PM, Shahidullah H, Humphreys F, et al. Systemic steroids and eczematised Darier’s disease [letter]. Br J Dermatol 1995; 133: 492PubMedCrossRef

60.

Shahidullah. H, Humphreys F, Beveridge GW. Darier’s disease: severe eczematization successfully treated with cyclosporin. Br J Dermatol 1994; 131 (5): 713–716PubMedCrossRef

61.

Larbre B, Nicolas JF, Frappaz A, et al. Cyclosporine et maladie de Darier. Ann Dermatol Venereol 1993; 120 (4): 310–311PubMed

62.

Oostenbrink JH, Cohen EB, Steijlen PM, et al. Oral contraceptives in the treatment of Darier-White disease: a case report and review of the literature. Clin Exp Dermatol 1996; 21 (6): 442–444PubMedCrossRef

63.

Epsy PD, Stone S, Jolly HW. Hormonal dependency in Darier’s disease. Cutis 1976; 17: 315–320

64.

du Plessis PJ, Jacyk WK. Essential fatty acids in the treatment of Darier’s disease. J Dermatol Treat 1998; 9: 97–101CrossRef

65.

Toombs EL, Peck GL. Electrosurgical treatment of etretinate-resistant Darier’s disease. J Dermatol Surg Oncol 1989; 15 (12): 1277–1280PubMed

66.

Zachariae H. Dermabrasion in Darier’s disease. Acta Derm Venereol 1979; 59 (2): 184–185PubMed

67.

Zachariae H. Dermabrasion of Hailey-Hailey disease and Darier’s disease [letter]. J Am Acad Dermatol 1992; 27: 136PubMedCrossRef

68.

Cohen KI, Kraemen KH, Peck GL. Cornifying Darier’s disease — a unique variant II: surgical treatment. Arch Dermatol 1976; 112 (4): 504–506PubMedCrossRef

69.

Wheeland RG, Gilmore WA. The surgical treatment of hypertrophic Darier’s disease. J Dermatol Surg Oncol 1985; 11 (4): 420–423PubMed

70.

Dellon AL, Chretien PB, Peck GL. Successful treatment of Darier’s disease by partial-thickness removal of skin. Plast Reconstr Surg 1977; 59 (6): 823–830PubMedCrossRef

71.

McFadden JP, Mayou BJ, Griffiths WAD. Darier’s disease of the groin treated by surgery [letter]. Br J Dermatol 1991; 125: 52CrossRef

72.

Beier C, Kaufmann R. Efficacy of erbium: YAG:laser ablation in Darier disease and Hailey-Hailey disease. Arch Dermatol 1999; 135 (4): 423–427PubMedCrossRef

73.

McElroy JA, Mehregan DA, Roenigk RK. Carbon dioxide laser vaporization of recalcitrant symptomatic plaques of Hailey-Hailey disease and Darier’s disease. J Am Acad Dermatol 1990; 23 (5): 893–897PubMedCrossRef

74.

Calderon MJ, Landa N, Gardeazabal J, et al. Combined retinoid plus surgical treatment of hypertrophic Darier’s disease. J Eur Acad Dermatol Venereol 1993; 2: 242–244CrossRef

Titel: Darier’s Disease
Epidemiology, Pathophysiology, and Management
verfasst von: Dr Susan M. Cooper
Susan M. Burge
Publikationsdatum: 01.02.2003
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 2/2003
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.2165/00128071-200304020-00003

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Darier’s Disease

Epidemiology, Pathophysiology, and Management

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2003

Effects of Alefacept on Health-Related Quality of Life in Patients with Psoriasis

Cutaneous Drug Reaction Case Reports

Ceramides and Skin Function

The Rationale for Using a Topical Retinoid for Inflammatory Acne

Ichthyosis

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie